Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
PaperCitations, authors & open-access status
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,874 citations, 2010 year and closed oa status.
1,874
Citations
2010
Year
closed
OA Status